The first quarter 2026 financial results and business update will be discussed during a conference call and webcast presentation today at 2:30 PM CET/8:30 AM ET. A webcast of the live call may be ...
Announced positive ELEVATE-44-201 Cohort 1 topline results in Duchenne muscular dystrophy showing favorable safety, tolerability and early functional benefit -- -- Company on track to report ELEVATE-4 ...
Q1 2026 Earnings Call May 7, 2026 10:00 AM EDTCompany ParticipantsTimothy FitzGerald - CEO & DirectorMark Salman ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results